BIO Investor Forum panel breaks down when, what, and why of IPOs
Biotech firms weighing an initial public offering (IPO) must consider timing, interest in their product, the macro environment—and whether they really need all the […]
BIO Investor Forum panel breaks down when, what, and why of IPOs Read More »